Owens & Minor

OMI

Market cap $340M

Owens & Minor sharpens its focus on home-based care with a $375M divestiture to Platinum Equity, unlocking cash, tax benefits, and long-term upside through a retained equity stake.

Standalone P&HS anticipated to benefit from Platinum's carve-out experience, sector expertise and commitment to growth Owens & Minor to retain a 5% equity stake in the business LOS ANGELES , Oct. 7, 2025 /PRNewswire/ -- Platinum Equity announced today that it has entered into a definitive agreement to acquire the Products & Healthcare Services ("P&HS") segment of Owens & Minor (NYSE: OMI). Owens & Minor will retain a five percent interest in the business.

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) today announced that it has entered into a definitive agreement for the sale of the Company's Products & Healthcare Services (P&HS) segment to Platinum Equity. Over the last several years, Owens & Minor has been strategically moving towards expanding its leadership position in the very attractive home-based care space. This transaction will allow the Company to focus on a simpler business model and allow for a more.

RICHMOND, Va.--(BUSINESS WIRE)--Effective September 1, 2025, Apria and Byram, part of the Owens & Minor family, entered a new national provider agreement with Optum Health.

NEW YORK , Sept. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 22, to coincide with the quarterly rebalance.

Owens & Minor, Inc. OMI reported worse-than-expected second-quarter earnings on Monday.

Owens & Minor, Inc.'s disastrous performance, weak margins, and strategic missteps have eroded investor confidence and driven OMI stock down 70% in a year. The planned sale of its core Products & Healthcare Services business highlights severe financial distress, with all proceeds earmarked for debt reduction. Guidance was slashed dramatically, revealing ongoing operational weakness and a multi-year turnaround with little benefit for equity holders in the near term.

Owens & Minor, Inc. (NYSE:OMI ) Q2 2025 Earnings Conference Call August 11, 2025 8:30 AM ET Company Participants Jacqueline Marcus - IR, Alpha IR Group LLC Edward A. Pesicka - President, CEO & Director Jonathan A.

U.S. stocks traded mixed this morning, with the Nasdaq Composite declining around 0.2% on Monday.

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the second quarter ended June 30, 2025. In connection with a likely sale of the Company's Products & Healthcare Services segment, the results herein, unless otherwise noted, reflect the Company's continuing operations which primarily represent what was previously the Patient Direct segment and certain functional operations. “We are in the final stages of our robust process for the divest.